data13F

CAI – Caris Life Sciences Inc

Held by 0 of 30 tracked investors in their latest 13F filing

Investors holding0
Combined shares0
Combined reported value$0

CAI chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Philippe Laffont0.00Closed0–Q3 2026
Stanley Druckenmiller0.00Closed0–Q3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Closed00.78
Q3 2026Philippe Laffont Closed00.36
Q1 2026Stanley Druckenmiller narrow view New1,894,4501.15
Q1 2026Cathie Wood Closed00.07
Q4 2025George Soros narrow view Closed00.04
Q4 2025Cathie Wood Added 66.6%408,7250.03
Q4 2025Philippe Laffont Reduced 3.2%9,819,9920.02

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q1 2026Stanley Druckenmiller narrow view New1,894,4501.15
Q4 2025Cathie Wood Added 66.6%408,7250.03

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Closed00.78
Q3 2026Philippe Laffont Closed00.36
Q1 2026Cathie Wood Closed00.07
Q4 2025George Soros narrow view Closed00.04
Q4 2025Philippe Laffont Reduced 3.2%9,819,9920.02

History

3 peakQ2 2026: 2 tracked investors
Q2 2025: 3 tracked investorsQ3 2025: 3 tracked investorsQ4 2025: 2 tracked investorsQ1 2026: 2 tracked investorsQ2 2026: 2 tracked investors
20252026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Philippe Laffont–9.82M9.82M9.82M10.14M10.14M––
Stanley Druckenmiller–1.89M1.89M–––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).